Literature DB >> 21914809

Allele-dependent processing pathways generate the endogenous human leukocyte antigen (HLA) class I peptide repertoire in transporters associated with antigen processing (TAP)-deficient cells.

Elena Lorente1, Ruth García, Daniel López.   

Abstract

The transporters associated with antigen processing (TAP) allow the supply of peptides derived from the cytosol to translocate to the endoplasmic reticulum, where they complex with nascent human leukocyte antigen (HLA) class I molecules. However, infected and tumor cells with TAP molecules blocked or individuals with nonfunctional TAP complexes are able to present HLA class I ligands generated by TAP-independent processing pathways. These peptides are detected by the CD8(+) lymphocyte cellular response. Here, the generation of the overall peptide repertoire associated with four different HLA class I molecules in TAP-deficient cells was studied. Using different protease inhibitors, four different proteolytic specificities were identified. These data demonstrate the different allele-dependent complex processing pathways involved in the generation of the HLA class I peptide repertoire in TAP-deficient cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21914809      PMCID: PMC3207402          DOI: 10.1074/jbc.M111.281808

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.

Authors:  K Schwarz; R de Giuli; G Schmidtke; S Kostka; M van den Broek; K B Kim; C M Crews; R Kraft; M Groettrup
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

Review 2.  Description of HLA class I- and CD8-deficient patients: Insights into the function of cytotoxic T lymphocytes and NK cells in host defense.

Authors:  Vincenzo Cerundolo; Henri de la Salle
Journal:  Semin Immunol       Date:  2006-09-12       Impact factor: 11.130

Review 3.  Proteasome inhibitors: valuable new tools for cell biologists.

Authors:  D H Lee; A L Goldberg
Journal:  Trends Cell Biol       Date:  1998-10       Impact factor: 20.808

4.  Concerted antigen processing of a short viral antigen by human caspase-5 and -10.

Authors:  Daniel López; Mercedes Jiménez; Margarita García-Calvo; Margarita Del Val
Journal:  J Biol Chem       Date:  2011-03-28       Impact factor: 5.157

5.  Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum.

Authors:  Loredana Saveanu; Oliver Carroll; Vivian Lindo; Margarita Del Val; Daniel Lopez; Yves Lepelletier; Fiona Greer; Lutz Schomburg; Doriana Fruci; Gabriele Niedermann; Peter M van Endert
Journal:  Nat Immunol       Date:  2005-05-22       Impact factor: 25.606

6.  Release of signal peptide fragments into the cytosol requires cleavage in the transmembrane region by a protease activity that is specifically blocked by a novel cysteine protease inhibitor.

Authors:  A Weihofen; M K Lemberg; H L Ploegh; M Bogyo; B Martoglio
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

7.  Tripeptidyl peptidase II is the major peptidase needed to trim long antigenic precursors, but is not required for most MHC class I antigen presentation.

Authors:  Ian A York; Nidhi Bhutani; Sophia Zendzian; Alfred L Goldberg; Kenneth L Rock
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

8.  Measles virus and canine distemper virus target proteins into a TAP-independent MHC class I-restricted antigen-processing pathway.

Authors:  Claudia Neumeister; Ralph Nanan; Tatjana I Cornu; Carsten G K Lüder; Volker Ter Meulen; Hussein Naim; Stefan Niewiesk
Journal:  J Gen Virol       Date:  2001-02       Impact factor: 3.891

9.  Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation.

Authors:  R Schirmbeck; K Melber; J Reimann
Journal:  Eur J Immunol       Date:  1995-04       Impact factor: 5.532

10.  Major histocompatibility complex class I viral antigen processing in the secretory pathway defined by the trans-Golgi network protease furin.

Authors:  B C Gil-Torregrosa; A Raúl Castaño; M Del Val
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

View more
  10 in total

1.  Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cells.

Authors:  Elena Lorente; Susana Infantes; Eilon Barnea; Ilan Beer; Ruth García; Fátima Lasala; Mercedes Jiménez; Carlos Vilches; François A Lemonnier; Arie Admon; Daniel López
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

2.  Role of metalloproteases in vaccinia virus epitope processing for transporter associated with antigen processing (TAP)-independent human leukocyte antigen (HLA)-B7 class I antigen presentation.

Authors:  Elena Lorente; Ruth García; Carmen Mir; Alejandro Barriga; François A Lemonnier; Manuel Ramos; Daniel López
Journal:  J Biol Chem       Date:  2012-02-01       Impact factor: 5.157

3.  CAR-T cells targeting a nucleophosmin neoepitope exhibit potent specific activity in mouse models of acute myeloid leukaemia.

Authors:  Guozhu Xie; Nikola A Ivica; Bin Jia; Yingzhong Li; Han Dong; Yong Liang; Douglas Brown; Rizwan Romee; Jianzhu Chen
Journal:  Nat Biomed Eng       Date:  2020-10-12       Impact factor: 25.671

Review 4.  Alternative Antigen Processing for MHC Class I: Multiple Roads Lead to Rome.

Authors:  Cláudia C Oliveira; Thorbald van Hall
Journal:  Front Immunol       Date:  2015-06-05       Impact factor: 7.561

5.  Complex antigen presentation pathway for an HLA-A*0201-restricted epitope from Chikungunya 6K protein.

Authors:  Elena Lorente; Alejandro Barriga; Juan García-Arriaza; François A Lemonnier; Mariano Esteban; Daniel López
Journal:  PLoS Negl Trop Dis       Date:  2017-10-30

6.  Designing of CD8+ and CD8+-overlapped CD4+ epitope vaccine by targeting late and early proteins of human papillomavirus.

Authors:  Satyavani Kaliamurthi; Gurudeeban Selvaraj; Aman Chandra Kaushik; Ke-Ren Gu; Dong-Qing Wei
Journal:  Biologics       Date:  2018-10-02

7.  Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S.

Authors:  Lukas Jac Hawinkels; Els Me Verdegaal; Tom J Harryvan; Marten Visser; Linda de Bruin; Léonie Plug; Lisa Griffioen; Arend Mulder; Peter A van Veelen; Gerbrand J van der Heden van Noort; Marlieke Lm Jongsma; Miranda H Meeuwsen; Emmanuel Jhj Wiertz; Saskia J Santegoets; James Ch Hardwick; Thorbald Van Hall; Jacques Neefjes; Sjoerd H Van der Burg
Journal:  J Immunother Cancer       Date:  2022-03       Impact factor: 13.751

8.  Diversity of natural self-derived ligands presented by different HLA class I molecules in transporter antigen processing-deficient cells.

Authors:  Elena Lorente; Susana Infantes; Eilon Barnea; Ilan Beer; Alejandro Barriga; Noel García-Medel; Fátima Lasala; Mercedes Jiménez; Arie Admon; Daniel López
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

9.  Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity.

Authors:  Francesca Parolini; Priscilla Biswas; Michela Serena; Francesca Sironi; Valentina Muraro; Elisabetta Guizzardi; Lucia Cazzoletti; Maria Teresa Scupoli; Davide Gibellini; Elisabetta Ugolotti; Roberto Biassoni; Alberto Beretta; Mauro Malnati; Maria Grazia Romanelli; Donato Zipeto
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

10.  Computational characterization of the peptidome in transporter associated with antigen processing (TAP)-deficient cells.

Authors:  Antonio J Martín-Galiano; Daniel López
Journal:  PLoS One       Date:  2019-01-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.